These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 23001041

  • 1. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
    Aoki I, Higuchi M, Gotoh Y.
    Oncogene; 2013 Aug 22; 32(34):3954-64. PubMed ID: 23001041
    [Abstract] [Full Text] [Related]

  • 2. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ, Lin FT, Lin WC.
    EMBO Rep; 2008 Sep 22; 9(9):907-15. PubMed ID: 18660752
    [Abstract] [Full Text] [Related]

  • 3. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, Steder M, Pützer BM.
    Cell Cycle; 2012 Aug 15; 11(16):3067-78. PubMed ID: 22871739
    [Abstract] [Full Text] [Related]

  • 4. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR, Blanch A, Lin DC, Ohh M, Irwin MS.
    J Biol Chem; 2006 Nov 10; 281(45):34096-103. PubMed ID: 16980297
    [Abstract] [Full Text] [Related]

  • 5. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
    Vera J, Schmitz U, Lai X, Engelmann D, Khan FM, Wolkenhauer O, Pützer BM.
    Cancer Res; 2013 Jun 15; 73(12):3511-24. PubMed ID: 23447575
    [Abstract] [Full Text] [Related]

  • 6. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
    Ozaki T, Okoshi R, Ono S, Kubo N, Nakagawara A.
    Biochem Biophys Res Commun; 2009 Sep 11; 387(1):143-8. PubMed ID: 19576172
    [Abstract] [Full Text] [Related]

  • 7. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
    Wu S, Murai S, Kataoka K, Miyagishi M.
    Biochem Biophys Res Commun; 2008 Jan 04; 365(1):75-81. PubMed ID: 17980704
    [Abstract] [Full Text] [Related]

  • 8. NEDDylation regulates E2F-1-dependent transcription.
    Loftus SJ, Liu G, Carr SM, Munro S, La Thangue NB.
    EMBO Rep; 2012 Sep 04; 13(9):811-8. PubMed ID: 22836579
    [Abstract] [Full Text] [Related]

  • 9. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK, Pyndiah S, Sakamuro D.
    Cell Death Differ; 2009 Dec 04; 16(12):1641-53. PubMed ID: 19629135
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
    Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, Gulino A, Levrero M.
    Nat Cell Biol; 2003 Jun 04; 5(6):552-8. PubMed ID: 12766778
    [Abstract] [Full Text] [Related]

  • 11. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M, Oswald C, Beinoraviciute-Kellner R, Stiewe T.
    Oncogene; 2006 Feb 09; 25(6):813-26. PubMed ID: 16205639
    [Abstract] [Full Text] [Related]

  • 12. Acetylation status of E2F-1 has an important role in the regulation of E2F-1-mediated transactivation of tumor suppressor p73.
    Ozaki T, Okoshi R, Sang M, Kubo N, Nakagawara A.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):207-11. PubMed ID: 19523927
    [Abstract] [Full Text] [Related]

  • 13. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
    Urist M, Tanaka T, Poyurovsky MV, Prives C.
    Genes Dev; 2004 Dec 15; 18(24):3041-54. PubMed ID: 15601819
    [Abstract] [Full Text] [Related]

  • 14. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M, Vikhanskaya F, Rainelli C, Sakai T, Broggini M.
    Nucleic Acids Res; 2003 Nov 15; 31(22):6624-32. PubMed ID: 14602923
    [Abstract] [Full Text] [Related]

  • 15. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
    Ozono E, Komori H, Iwanaga R, Tanaka T, Sakae T, Kitamura H, Yamaoka S, Ohtani K.
    Genes Cells; 2012 Aug 15; 17(8):660-72. PubMed ID: 22702391
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH, Wei WY, Cao WL, Zhang XS, Xie YB, Xiao Q.
    BMC Cancer; 2014 Dec 03; 14():904. PubMed ID: 25466554
    [Abstract] [Full Text] [Related]

  • 17. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM, Bhattacharya S, Johnson LR.
    Apoptosis; 2011 Jan 03; 16(1):35-44. PubMed ID: 20812030
    [Abstract] [Full Text] [Related]

  • 18. Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1.
    Wu S, Murai S, Kataoka K, Miyagishi M.
    Nucleic Acids Symp Ser (Oxf); 2007 Jan 03; (51):347-8. PubMed ID: 18029729
    [Abstract] [Full Text] [Related]

  • 19. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
    Chen D, Chen Y, Forrest D, Bremner R.
    Cell Death Differ; 2013 Jul 03; 20(7):931-40. PubMed ID: 23558950
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
    Liontos M, Niforou K, Velimezi G, Vougas K, Evangelou K, Apostolopoulou K, Vrtel R, Damalas A, Kontovazenitis P, Kotsinas A, Zoumpourlis V, Tsangaris GT, Kittas C, Ginsberg D, Halazonetis TD, Bartek J, Gorgoulis VG.
    Am J Pathol; 2009 Jul 03; 175(1):376-91. PubMed ID: 19541929
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.